Attempts to use alpha-melanotropin-containing melphalan in melanoma patients.
C.P.O. Centre Pluridisciplinaire d'Oncologie-CHUV Niveau 06, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
F J
FJ
Lejeune
G E
GE
Ghanem
D000818:Animals; D006801:Humans; D007457:Iodine Radioisotopes; D008113:Liver Neoplasms / Q000000981:diagnostic imaging / Q000556:secondary; D008545:Melanoma / Q000000981:diagnostic imaging / Q000188:drug therapy*; D008546:Melanoma, Experimental / Q000378:metabolism; D008558:Melphalan / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000627:therapeutic use*; D051379:Mice; D008810:Mice, Inbred C57BL; D009362:Neoplasm Metastasis; D010865:Pilot Projects; D011877:Radionuclide Imaging; D011979:Receptors, Pituitary Hormone / Q000378:metabolism; D000521:alpha-MSH / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000627:therapeutic use*
D007457:Iodine Radioisotopes; D011979:Receptors, Pituitary Hormone; C081716:alpha-MSH-melphalan conjugate; D000521:alpha-MSH; C029446:MSH receptor; D008558:Melphalan